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19th CardioVascular Summit: TCTAP 2014transfusion) occurred in the procedure. The rate of all-cause death was 7.2%. Restenotic
lesion (p¼0.004), chronic total occlusion (p¼0.03), TASC type C or D lesion
(p¼0.009) and smaller stent diameter (p¼0.02) have an effect on restenosis.
Table below shows the correlation between these parameters and restenosis.
Conclusion: FP stenting with DES yielded acceptable outcomes in short-term.TCTAP A-105
Comparison on Vascular Response Between Bare-metal Nitinol
Stent Implantation and Paclitaxel-eluting Nitinol Stent Implantation in the
Superﬁcial Femoral Artery Lesion Assessed by Intravascular Ultrasound
Kojiro Miki, Kenichi Fujii, Masashi Fukunaga, Masashi Nishimura,
Tetsuo Horimatsu, Tohru Masuyama
Hyogo College of Medicine, Nishinomiya, Japan
Background: Although previous intravascular ultrasound (IVUS) studies reported
that drug-eluting stent (DES) have successfully decreased in-stent restenosis (ISR) by
inhibiting neointimal hyperplasia (NIH) in the coronary artery lesion, no IVUS data
for NIH after DES implantation in the superﬁcial femoral artery (SFA) has been
published.
Methods:We analyzed 38 SFA lesions that underwent endovascular treatment (EVT)
with self-expanding bare-metal nitinol stents (25 lesions, BMS group) or paclitaxel-
eluting nitinol stents (13 lesions, PES group). At 6 months after EVT, follow-up
angiography and IVUS examination were performed in all cases. The serial IVUS
volumetric analysis was performed after stent deployment and at follow-up. Vessel,
stent, lumen, plaque and neointimal volumes were calculated using Simpson’s rule.
Mean stent, lumen and neointimal areas were computed as the volume divided by the
stent length. Mean late lumen area loss was deﬁned as mean lumen area immediately
after initial deployment - mean lumen area at follow-up. The primary end point of this
study was mean late lumen loss at 6-month follow-up. The secondary end point was
angiography-deﬁned ISR rate at 6 months.
Results: The mean follow-up period was 189  39 days. Mean neointimal area was
smaller in PES group compared to BMS group (3.3  1.0 mm2 vs. 10.2  4.1 mm2,
p<0.001, ﬁgure). Mean late lumen loss was signiﬁcantly lower in PES group
compared to BMS group (-2.3  3.7 mm2 vs. 2.1  4.7 mm2, p<0.05, ﬁgure).
Angiography-deﬁned ISR rate was similar between two groups.
Conclusion: EVT with DES in the SFA lesions might decrease NIH that associated
with ISR.S30 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP AbstractsTCTAP A-106
Effects of Percutaneous Transluminal Renal Angioplasty on Blood Pressure
Evaluated with 24-hour Monitoring
Kentaro Jujo, Ahsung Kim, Issei Ishida, Yuki Suzuki, Katsumi Saito
Nishiarai Heart Center Hospital, Tokyo, Japan
Background: Percutaneous transluminal renal angioplasty (PTRA) improves patency
in atherosclerotic renal artery stenosis (ARAS). However, OFFICE blood pressure
(BP) improvement as primary purpose was achieved in only 20-40% of patients
performed PTRA. The purpose of this study was to clarify the effects of PTRA on BP
response by 24-hour BP monitoring, and identify preoperative features that predict a
sufﬁcient BP response to PTRA.
Methods: Out of 1191 consecutive patients underwent coronary angiography, 505
patients with hypertension were followed by abdominal aortography for etiological
screening of hypertension in a single cardiovascular center from Jan 2010 till Oct
2012. Among patients with angiographically signiﬁcant stenosis, 30 patients with
more than 20 mmHg translesional pressure gradient at renal artery under hyperemic
condition were underwent PTRA. Ambulatory blood pressure monitoring (ABPM)
was performed before and 1 month after PTRA, and patients were categorized as
‘Responders’ depending on average systolic BP decrease more than 10 mmHg.
Physiological, echorenographic and hormonal parameters were retrospectively
compared between Responders and Non-responders.
Results: There was no signiﬁcant difference in BP at admission between 13 Responders
and 17 Non-responders (systolic, 148  18 vs. 145  17, p¼0.62; diastolic, 70  9.3
vs. 68  14, p¼0.62; mean, 96  7.8 vs. 93  14 mmHg, p¼0.55). Baseline BP on
ABPM was signiﬁcantly high in Responders (systolic, 148  10 vs. 127  16, p<0.01;
diastolic, 80 7.2 vs. 71 8.3, p<0.01; mean, 102 6.4 vs. 89 10 mmHg, p<0.01).
Even BP 2 days after PTRA was not different between the groups (systolic, 130  19
vs. 133  17, p¼0.68; Δsystolic, -19  17 vs. -12  15, p¼0.31), Responders achieved
16 6.7 mmHg decrease in systolic BP on ABPM 1 month after PTRA, did not in Non-
responders (-6.9  13 mmHg, p<0.01). On clinical backgrounds and prehospital
medication, there was no statistical difference. Also, translesional pressure gradient at
hyperemic condition detected by pressure wire was not statistically different between the
groups (36  32 vs. 30  25 mmHg, p¼0.60). In terms of echorenographic parameters,
acceleration time (AT) at baseline was signiﬁcantly LOWER in Responders (72  19
vs. 92  27 msec., p¼0.028), yet other parameters including renal/aorta ratio (RAR),
peak systolic velocity (PSV) or resistive index (RI) was not signiﬁcantly different be-
tween the groups (RAR, 3.7  1.7 vs. 3.7  1.9, p¼0.94; PSV, 218  94 vs. 214  91
cm/sec., p¼0.90; RI, 0.8  0.1 vs. 0.8  0.1, p¼0.56). Assessment of hormonal pa-
rameters suggested that either plasma renin activity (PRA), aldosterone concentration
(PAC) or BNP was not preoperative predictor for BP response to PTRA (PRA, 3.8 
5.3 vs. 2.5  4.9 ng/mL/h, p¼0.50; PAC, 79  29 vs. 56  38 pg/mL, p¼0.078; BNP,
80 75 vs. 178  200 pg/mL, p¼0.10). However, interestingly, baseline renal function
was signiﬁcantly worse in Responders (serum creatinine, 1.47  0.67 vs. 1.01  0.34
mg/dL, p¼0.021; eGFR, 36.0  21 vs. 52.4  22 mL/min/1.73m2, p¼0.037).
Conclusion: The present study demonstrated that ofﬁce BP did not represent patients’
daily hemodynamic status, and high 24-hour BP was a potent predictor for sufﬁcient
BP response to PTRA. These ﬁndings may help clinicians to optimize risk-beneﬁt
proﬁle of PTRA and reduce unnecessary intervention.
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Safety and Efﬁcacy of True Lumen Tracking Recanalization for the Chronic
Total Occlusions of Iliac and Femoral Artery
Rie Sugawara, Ren Kawaguchi, Yusuke Miyaishi, Hakuken Kan, Hiroshi Hoshizaki,
Shigeru Oshima
Gunma Prefectural Cardiovascular Center, Maebashi, Japan
Background: Chronic total occlusions(CTO) is still remains as one of the challenging
lesion in the ﬁeld of endovascular treatment(EVT). We aimed to investigate the safety
and efﬁcacy of EVT using true lumen tracking with 0.018 inch stiff guide wire for the
CTO of the iliac and femoral artery.
Methods: From January 2008 to July 2013, consecutive 70 CTO of iliac (n¼43) and
femoral arteries (n¼27) that performed EVT in our center were enrolled for this study.
True lumen tracking using with 0.018 inch stiff guide wire under intravascular
ultrasound(IVUS) guidance was attempted for all cases. The employment of bidi-
rectional approach was left to the operator0s decision. Procedure success which
deﬁned as residual stenosis less than 50% with Thrombolysis in Myocardial Infarc-
tion(TIMI) 3 ﬂow was investigated. The occurrence of thromboembolism and per-
forations related to procedure were investigated as the safety endpoint.
Results: TASC II TypeB/ C/ D were observed 31/ 5/ 34cases. Mean lesion length in iliac
lesion and femoral lesion was 72.6  37.7 mm and 78.0  30.7 mm respectively.
Bidirectional approach was performed for 27 cases. Successful guide wire crossing was
observed for 37 cases(86.0%) of iliac lesion and 22cases (81.5%) of femoral lesions.
Complete true lumen tracking was observed for 27cases (62.8%) of iliac lesion and
20cases (74.1%) of femoral lesions. No thromboembolism and one case of vessel
perforation after stenting were observed. Procedure success was achieved 37 cases
(86.0%) of iliac lesion and 22 cases (81.5%) of femoral lesions after further balloon
angioplasty or stenting. Univariate analysis showed that the heavy calciﬁcation at the CTO
site was signiﬁcantly related to guide wire crossing failure. (26.3% vs 3.1%:P¼0.009)
Conclusion: The true lumen tracking using with 0.018 inch stiff guide wire under
IVUS guidance seems have acceptable safety proﬁle and effective for successful
recanalization of CTO of iliac and femoral arteries./ORAL/Peripheral Vascular Intervention (Non-carotid, Non-neurovascular)
